21 research outputs found

    Volume CXIV, Number 4, November 7, 1996

    Get PDF
    Objective: Turner syndrome (TS) is a chromosomal disorder caused by complete or partial X chromosome monosomy that manifests various clinical features depending on the karyotype and on the genetic background of affected girls. This study aimed to systematically investigate the key clinical features of TS in relationship to karyotype in a large pediatric Turkish patient population.Methods: Our retrospective study included 842 karyotype-proven TS patients aged 0-18 years who were evaluated in 35 different centers in Turkey in the years 2013-2014.Results: The most common karyotype was 45,X (50.7%), followed by 45,X/46,XX (10.8%), 46,X,i(Xq) (10.1%) and 45,X/46,X,i(Xq) (9.5%). Mean age at diagnosis was 10.2±4.4 years. The most common presenting complaints were short stature and delayed puberty. Among patients diagnosed before age one year, the ratio of karyotype 45,X was significantly higher than that of other karyotype groups. Cardiac defects (bicuspid aortic valve, coarctation of the aorta and aortic stenosis) were the most common congenital anomalies, occurring in 25% of the TS cases. This was followed by urinary system anomalies (horseshoe kidney, double collector duct system and renal rotation) detected in 16.3%. Hashimoto's thyroiditis was found in 11.1% of patients, gastrointestinal abnormalities in 8.9%, ear nose and throat problems in 22.6%, dermatologic problems in 21.8% and osteoporosis in 15.3%. Learning difficulties and/or psychosocial problems were encountered in 39.1%. Insulin resistance and impaired fasting glucose were detected in 3.4% and 2.2%, respectively. Dyslipidemia prevalence was 11.4%.Conclusion: This comprehensive study systematically evaluated the largest group of karyotype-proven TS girls to date. The karyotype distribution, congenital anomaly and comorbidity profile closely parallel that from other countries and support the need for close medical surveillance of these complex patients throughout their lifespa

    TÜRKİYE JEOTERMAL POTANSİYELİNİN ISI AKISI HESAPLAMASIYLA DEĞERLENDİRİLMESİ

    No full text
    Bu çalışma da, Türkiye’deki bilinen jeotermal sahaların dışındaki yeni sahaların belirlenmesine yönelik olarak Türkiye’nin ısı akısı dağılımı araştırılmıştır. Bu amaçla, havadan manyetik verilerinden güç spektrumu yöntemiyle elde edilen Curie noktası derinliğinden yararlanılarak jeotermal gradient hesaplanmıştır. Jeotermal gradient değerleri ile kayaç ısı iletim değerleri çarpılarak Türkiye’nin ısı akısı haritası elde edilmiştir. Türkiye geneli ısı akısı haritasında ortalama değerin 74 mW/m2 olduğu belirlenmiştir. Bu değer, Türkiye’de, dünya ortalamasının üzerinde bir jeotermal enerji kaynağının varlığına işaret etmektedir. Türkiye’nin jeotermal açıdan en önemli bölgesi 200 mW/m2 aşan değeri ile Aydın ve çevresini kapsayan alandır. Buna karşın, Aksaray, Niğde, Karaman ve Konya ile sınırlanan alanda bu değer 30 mW/m2 değerin altına kadar düşmektedir. Doğu Karadeniz, Doğu ve Güneydoğu Anadolu bölgeleri için ise ayrıntılı ek çalışma yapılması gerekliliği görülmüştür

    A survey analysis of thoracic surgeons in Turkey on mediastinal investigation of lung cancer

    No full text
    A total of 59 general thoracic surgeons of 21 academically based thoracic surgery centres in Turkey were surveyed to identify the attitudes toward mediastinal investigations in patients with lung cancer. The surgeons were asked 16 questions in five separate groups by survey questionnaire. Analyses of the replies were as follows: Group I: 37 (62.7%) of the respondents were working in 11 centres where >100 patients are admitted or referred for lung cancer annually. More than 50 thoracotomies are performed for lung cancer annually in one third of the centres in which 28 (47.5%) respondents work. Group II: Among the diagnostic methods for evaluating mediastinum, surgeons most commonly used the computed tomography, mediastinoscopy, mediastinotomy and scalene lymph node biopsy. Invasive staging was done routinely by ten (16.9%) and selectively by 44 (74.6%). Group III: In patients with preoperatively histologically proven ipsilateral mediastinal lymph node involvement, 39 (66.1%) were advocates of operating. When the lymph node(s) was found to be positive at operation, 33 of them (55.9%) gave the decision with respect to the number, size and presence of pericapsular invasion of the node(s), while 24 (40.7%) decided to perform lung resection in every situation. Group IV: All accessible mediastinal nodes were said to be removed at thoracotomy by 37 (62.7%). Group V: Currently available methods for mediastinal investigation were found to be partially sufficient by 37 (62.7%). The most important factor in predicting postoperative survival was selected as nodal status by 27 (45.8%). It is noticed that nearly all thoracic surgeons in Turkey perform mediastinal investigation preoperatively in patients with lung cancer, however, the impact of lymph node status needs to be more commonly appreciated

    A Novel Blockchain-Based Scientific Publishing System

    No full text
    The scientific publishing industry is dominated by a few publishers that use centralized systems, which decrease the quality of studies and make the publication process longer. Traditional publication systems generally have high publication costs, slow and biased review processes, copyrights held by publishers, lack of rewards for contributors, lack of connection among researchers, etc. Accordingly, we propose a decentralized blockchain-based scientific publication platform to eliminate the traditional publication system deficiencies. The proposed system uses Ethereum smart contracts to accelerate the publication process and abate the biased evaluation process while reducing the publication cost. The proposed model also improves the quality of scientific studies by adding new features to the publication process. The proposed system increases the number of publishers, makes the publication process fully traceable, and makes scientific papers globally available to anyone with a small fee. In addition, the system provides journals with decentralized models and integrates scientific papers with related data or datasets. The editors, reviewers, and cited authors are also rewarded. The proposed system has been implemented using Ethereum Virtual Machine (EVM), which consists of a front-end, middleware, and back-end. When an author submits a manuscript for evaluation, the system automatically finds the most appropriate editors and reviewers for related fields. After the publication process finishes, editors, reviewers, cited authors, and other contributors are rewarded as a system token-based cryptocurrency

    Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

    No full text
    Purpose This study evaluated the efficacy and safety of everolimus (EVE) plus exemestane (EXE) in hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (MBC) patients in real-life settings. Methods Overall, 204 HR+, HER2- MBC patients treated with EVE + EXE after progressing following prior endocrine treatment were included. Overall survival (OS) and progression-free survival (PFS) and safety data were analyzed. Results The objective response rate, median PFS, and median OS were 33.4%, 8.9 months, and 23.4 months, respectively. Multivariate analysis revealed that negative progesterone receptor status was a significant determinant of poor treatment response (p = 0.035) and PFS (p = 0.024). The presence of bone-only metastasis was associated with better treatment response (p = 0.002), PFS (p 0.001), and OS (p = 0.001). Conclusion We confirmed the favorable efficacy and safety profile of EVE + EXE for HR+, HER - MBC patients

    Prospective Evaluation of Chromosomal Breakages in Hemophiliac Children after Radioisotope Synovectomy with Yttrium(90) and Rhenium(186).

    No full text
    50th Annual Meeting of the American-Society-of-Hematology/ASH/ASCO Joint Symposium -- DEC 06-09, 2008 -- San Francisco, CAWOS: 000262104701441Amer Soc Hematol, Sanofi Aventis U.S
    corecore